Cargando…

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV

BACKGROUND: The lateral flow urine lipoarabinomannan (LF‐LAM) assay Alere Determine™ TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active tuberculosis in HIV‐positive people with severe HIV disease. This review update asks the question, "does new evidence justif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjerrum, Stephanie, Schiller, Ian, Dendukuri, Nandini, Kohli, Mikashmi, Nathavitharana, Ruvandhi R, Zwerling, Alice A, Denkinger, Claudia M, Steingart, Karen R, Shah, Maunank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802713/ https://www.ncbi.nlm.nih.gov/pubmed/31633805 http://dx.doi.org/10.1002/14651858.CD011420.pub3

Ejemplares similares

Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
por: Nathavitharana, Ruvandhi R, et al.
Publicado: (2021)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
por: Shah, Maunank, et al.
Publicado: (2016)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
por: Shapiro, Adrienne E, et al.
Publicado: (2021)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2022)

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study
por: Thit, Swe Swe, et al.
Publicado: (2017)

Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests
por: MacLean, Emily L., et al.
Publicado: (2022)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India
por: Acharya, Shrikala, et al.
Publicado: (2022)

Top Questions in the Diagnosis and Treatment of Pulmonary M. abscessus Disease
por: Nathavitharana, Ruvandhi R, et al.
Publicado: (2019)

Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for Diagnosis of Active Tuberculosis in HIV-Infected Adults: a Prospective Cohort Study
por: Na Songkhla, Munjit, et al.
Publicado: (2017)

Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study
por: Songkhla, Munjit Na, et al.
Publicado: (2019)

Sensitivity of the lateral flow urine lipoarabinomannan assay in ambulant adults with advanced HIV disease: data from the TB Fast Track study
por: Tlali, Mpho, et al.
Publicado: (2020)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa
por: Mukora, R., et al.
Publicado: (2018)

Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
por: Broger, Tobias, et al.
Publicado: (2020)

Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis
por: Yakhelef, Nadia, et al.
Publicado: (2020)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
por: Kebede, Wakjira, et al.
Publicado: (2021)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients
por: Connelly, John T., et al.
Publicado: (2021)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Isolation and purification of lipoarabinomannan from urine of adults with active TB
por: Cantera, J. L., et al.
Publicado: (2023)

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
por: Drain, Paul K., et al.
Publicado: (2016)

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
por: Albert, Heidi, et al.
Publicado: (2016)

TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays
por: Zwerling, Alice, et al.
Publicado: (2012)

Can AI technologies close the diagnostic gap in tuberculosis?
por: Tzelios, Christine, et al.
Publicado: (2021)

Addressing TB-related mortality in adults living with HIV: a review of the challenges and potential solutions
por: Sullivan, Amanda, et al.
Publicado: (2022)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
por: Broger, Tobias, et al.
Publicado: (2019)

Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria – experiences from the Danish Cystic Fibrosis cohort study
por: Qvist, Tavs, et al.
Publicado: (2014)

Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
por: Steingart, Karen R., et al.
Publicado: (2011)

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2016)

Closing gaps in the tuberculosis care cascade: an action-oriented research agenda
por: Subbaraman, Ramnath, et al.
Publicado: (2020)

Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana–findings from the DETECT HIV-TB study
por: Bjerrum, Stephanie, et al.
Publicado: (2015)

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria
por: Wood, Robin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fg6cslp7v0ofie4t3q162msegk